|
SUPT6H expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.441600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.598120E-02 |
| Normal-vs-Stage2 |
1.179620E-01 |
| Normal-vs-Stage3 |
1.576790E-03 |
| Normal-vs-Stage4 |
1.968330E-02 |
| Stage1-vs-Stage2 |
6.083600E-01 |
| Stage1-vs-Stage3 |
3.291800E-01 |
| Stage1-vs-Stage4 |
8.721600E-01 |
| Stage2-vs-Stage3 |
2.308800E-01 |
| Stage2-vs-Stage4 |
5.536800E-01 |
| Stage3-vs-Stage4 |
5.609200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.620400E-03 |
| Normal-vs-AfricanAmerican |
9.001200E-01 |
| Normal-vs-Asian |
8.919800E-02 |
| Caucasian-vs-AfricanAmerican |
6.811800E-02 |
| Caucasian-vs-Asian |
6.737400E-01 |
| AfricanAmerican-vs-Asian |
2.220000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.533530E-02 |
| Normal-vs-Female |
6.076800E-03 |
| Male-vs-Female |
7.560600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.177700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.397400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.922700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.374210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.672600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.352400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.692400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.224400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.935400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.973200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.576950E-03 |
| Classical-VS-Follicular |
3.420700E-04 |
| Classical-VS-Other |
2.396400E-01 |
| Classical-VS-Normal |
9.527600E-02 |
| Tall-VS-Follicular |
8.108000E-01 |
| Tall-VS-Other |
8.267800E-01 |
| Tall-VS-Normal |
4.845400E-04 |
| Follicular-VS-Other |
9.541800E-01 |
| Follicular-VS-Normal |
3.424300E-04 |
| Other-VS-Normal |
7.359700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.736800E-03 |
| Normal-vs-N1 |
8.435900E-03 |
| N0-vs-N1 |
5.773000E-01 |
|
|
